Resources · Press
News and announcements.
Press releases and coverage. For media requests, use the contact form and choose Press.
Joseph Hayhurst shares his founder story at 1 Million Cups Kansas City
HMT's founder and CEO presented at 1 Million Cups Kansas City on September 23, 2026, talking about his path from surgery training to building HMT.
Dr. Mazin Al-Kasspooles, Dr. Tyler Mouw and David Alverson join HMT
Two senior clinical advisors with deep surgical oncology experience and a chief financial officer have joined Hayhurst Medical Technologies.
Press kit
Logos and brand assets.
Official HMT identity assets, version 1.2.0, free to use in editorial coverage.
Complete press kit (ZIP, 1.4 MB). All logos (SVG and transparent PNG), the logo usage guide and the brand manifest.
Individual files
- Primary logo (SVG) Default. Copper mark and navy wordmark, for light backgrounds.
- Primary logo (PNG, 2400 px) Transparent background.
- Logo for dark backgrounds (SVG) White version.
- Stacked logo (SVG) For narrow layouts.
- Mark only (SVG) The Close Set H, without the wordmark.
- Social avatar (SVG) White mark on navy.
- Logo usage guide (PDF) Clear space, minimum sizes, colors.
- Brand manifest (JSON) Machine-readable palette, usage rules and file list.
Using the logo
- Use the supplied files; do not retype the wordmark, redraw the mark, or add shadows, outlines or gradients.
- Keep at least one cord width of clear space around the logo. Minimum widths: horizontal logo 240 px, stacked 180 px, mark 32 px.
- Colors: navy #152536, copper #CF6D46, warm grey #CCC8C3, white #FFFFFF.
For interviews or other media requests, use the contact form and choose “Press or media.”
About HMT
Company boilerplate.
Hayhurst Medical Technologies (HMT) is a cancer data company building the prospective cancer intelligence network. HMT finds the cancer patients the system misses and gets them to the right care, and in doing so builds the prospective, outcome-linked cancer registry that does not exist yet. Its software reads the reports every cancer patient already generates, structures the findings, and suggests the next step and qualified specialists nearby, with the clinician deciding. HIPEC and peritoneal disease are where HMT starts. Founded by physicians in Kansas City, Missouri, in 2026, HMT is a Delaware corporation.